Alzamend Neuro reported net income of -$2.87M for the quarter ended Apr 2026. This income statement covers 25 quarters of results from Apr 2020 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.08M | 0.07M | 0.08M | 0.10M | 0.39M | 0.73M | 0.45M | 2.11M | 3.80M | 3.80M | 3.34M | |||||
| Operating items | |||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.92M | 1.75M | 0.87M | 1.66M | 1.38M | 1.53M | 2.89M | 1.65M | 2.37M | 2.00M | 1.91M | 0.18M | 0.21M | 0.31M | 0.45M | 0.45M | 1.74M | 0.18M | 1.28M | 0.43M | |||||
| Selling, General & AdministrativeSG&A | 1.39M | 1.83M | 1.68M | 2.21M | 1.66M | 1.57M | 2.53M | 1.66M | 1.16M | 0.90M | 0.75M | 0.67M | 0.76M | 1.05M | 0.59M | 0.69M | 0.96M | 0.82M | 0.92M | 2.44M | |||||
| Operating ExpensesOpex | 2.31M | 3.58M | 2.56M | 3.87M | 3.04M | 3.11M | 5.42M | 3.31M | 3.53M | 2.90M | 2.66M | 0.85M | 0.96M | 1.36M | 1.04M | 1.14M | 2.70M | 1.00M | 2.20M | 2.87M | |||||
| Operating IncomeOp. Inc | -2.31M | -3.58M | -2.56M | -3.87M | -3.04M | -3.11M | -5.42M | -3.31M | -3.53M | -2.90M | -2.66M | -0.85M | -0.96M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| EBIT | -2.31M | -3.58M | -2.56M | -3.87M | -3.04M | -3.11M | -5.42M | -3.31M | -3.53M | -2.90M | -2.66M | -0.85M | -0.96M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Non-operating items | |||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.02M | 0.02M | 602.00 | 0.00M | 0.00M | 0.00M | 519.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 509.00 | 0.00M | 0.00M | 0.00M | 150.00 | |||||
| Other Non Operating IncomeOther Non Op Inc. | |||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.01M | -0.02M | -0.02M | 0.00M | -0.00M | -0.00M | -0.00M | -519.00 | -0.00M | -0.00M | -0.00M | -0.00M | -0.01M | -0.00M | -0.00M | -509.00 | -0.00M | -0.00M | -0.00M | 928.00 | |||||
| Net income details | |||||||||||||||||||||||||
| EBT | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Profit After TaxPAT | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Income from Continuing OperationsIncome (Continuing) | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Consolidated Net IncomeConsol Net Inc. | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Income towards Parent CompanyParent Net Inc | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.42M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Net Income towards Common StockholdersNet Income | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.42M | -1.07M | -1.64M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Additional items | |||||||||||||||||||||||||
| EPS (Basic) | -37.02 | -52.00 | -37.16 | -58.69 | -42.06 | -43.07 | -74.49 | -45.76 | -48.38 | -39.85 | -33.97 | -11.33 | -11.27 | -3.61 | -1.75 | -3.64 | -1.28 | -0.30 | -0.58 | -0.86 | |||||
| EPS (Diluted) | -37.02 | -52.00 | -36.88 | -58.69 | -42.06 | -43.07 | -74.49 | -45.76 | -48.38 | -39.85 | -33.97 | -11.33 | -11.27 | -3.61 | -1.75 | -3.64 | -1.28 | -0.30 | -0.58 | -0.86 | |||||
| Shares Outstanding | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.08M | 0.08M | 0.09M | 0.39M | 0.61M | 0.45M | 2.11M | 3.38M | 3.80M | 3.34M | |||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.06M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.07M | 0.08M | 0.08M | 0.09M | 0.39M | 0.61M | 0.45M | 2.11M | 3.38M | 3.80M | 3.34M | |||||
| EBITDA | -2.31M | -3.58M | -2.56M | -3.87M | -3.04M | -3.11M | -5.42M | -3.31M | -3.53M | -2.90M | -2.66M | -0.85M | -0.96M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Interest ExpensesInt Expense | 0.01M | 0.02M | 0.02M | 602.00 | 0.00M | 0.00M | 0.00M | 519.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 509.00 | 0.00M | 0.00M | 0.00M | 150.00 |